Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed
French Pharma Reports €1.33Bn Q1 Consumer Health Sales Helped By Price Increases
After 118.2% cough/cold sales growth leads 17% overall consumer business growth, Sanofi points to still stronger days ahead while keeping the business under the same roof with its pharmaceutical and vaccine divisions.
